ScreenerHero
MVIRMedivir AB (publ)
STO · SE · Healthcare · Biotechnology · medivir.com
1.900SEK+2.15%Mkt Cap: 112.30M $P/E: —

Medivir AB (publ), a pharmaceutical company, focuses on the development and commercialization of medical treatments in areas of high unmet medical need in Sweden, the Nordic region, the rest of Europe, and internationall…

Industry Peers

Biotechnology
Screen all
VX1
Vertex Pharmaceuticals Incorporated
$130.23BUSDP/E 32.1
VRTX
Vertex Pharmaceuticals Incorporated
$139.84BUSDP/E 32.2
REGN
Regeneron Pharmaceuticals, Inc.
$85.11BUSDP/E 20.4
MRNA
Moderna, Inc.
$69.62BUSD
ARGX
argenx SE
$61.34BUSDP/E 39.8
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$46.01BUSD
ONC
BeOne Medicines AG
$41.76BUSDP/E 66.2
RPRX
Royalty Pharma Plc Class A
$35.67BUSDP/E 33.2
ALNY
Alnylam Pharmaceuticals, Inc.
$32.46BUSDP/E 42.3
INSM
Insmed Incorporated
$28.53BUSD
22UA
BioNTech SE
$26.14BUSD
INCY
Incyte Corporation
$25.79BUSDP/E 16.2
GMAB
Genmab A/S
$20.83BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$17.03BUSDP/E 20.0
BBIO
BridgeBio Pharma, Inc.
$16.41BUSD
EXEL
Exelixis, Inc.
$13.48BUSDP/E 17.1
BMRN
BioMarin Pharmaceutical Inc.
$13.42BUSDP/E 187.4
CORT
Corcept Therapeutics Incorporated
$12.87BUSDP/E 264.5
HeadlineSourceTime
Yesterday
Medivir AB (STU:MVR0) (Q2 2026) Earnings Call Highlights: Advancing Fostrox in HCC and MIV-711 ...

Medivir AB (STU:MVR0) reports strong progress across its pipeline, with key data readouts expected in 2027 and a strengthened cash position to fund operations into 2030.

GuruFocus.com
Medivir minskar förlusten
Affärsvärlden
Older
Lindahl rådgivare till Medivir i riktad nyemission om cirka 140 MSEK
DDagens Juridik
Bennet-bolaget vill ta in 130 Mkr
Dagens industri
Maxim höjer Medivir till köp (behåll), riktkurs 0,75 kronor
Affärsvärlden
Medivir AB (FRA:MVR0) Q4 2025 Earnings Call Highlights: Strategic Advances and Financial Resilience

Medivir AB (FRA:MVR0) showcases significant pipeline progress and a robust financial position despite facing developmental challenges.

GuruFocus.com
Läkemedelsbolaget rusar tvåsiffrigt på rapport
Privata Affärer
Finansmannens snabba klipp: 190 procent på fem dagar
EEFN
Carl Bennet AB blir storägare i Medivir
BBiostock
Medivir AB (STU:MVR0) Q3 2025 Earnings Call Highlights: Strategic Moves and Financial Adjustments

Medivir AB (STU:MVR0) reports steady revenue, improved operating loss, and strategic initiatives to bolster its pipeline and financial position.

GuruFocus.com
Medivir AB (STU:MVR0) Q2 2025 Earnings Call Highlights: Strategic Advances Amid Financial Challenges

Medivir AB (STU:MVR0) reports promising clinical developments and patent extensions, while navigating funding hurdles to sustain its innovative pipeline.

GuruFocus.com
Medivir ser varaktig klinisk nytta med fostrox
BBiostock
Insynshandel Medivir | Aktuell data och historik
Börskollen
Medivir
carnegie.se